Abstract:Epigenetic alterations are a hallmark of aging and age-related diseases. Computational models using DNA methylation data can create "epigenetic clocks" which are proposed to reflect "biological" aging. Thus, it is important to understand the relationship between predictive clock sites and aging biology. To do this, we examined over 450,000 methylation sites from 9,699 samples. We found ~20% of the measured genomic cytosines can be used to make many different epigenetic clocks whose age prediction performance surpasses that of telomere length. Of these predictive sites, the average methylation change over a lifetime was small (~1.5%) and these sites were under-represented in canonical regions of epigenetic regulation. There was only a weak association between "accelerated" epigenetic aging and disease. We also compare tissue-specific and pan-tissue clock performance. This is critical to applying clocks both to new sample sets in basic research, as well as understanding if clinically available tissues will be feasible samples to evaluate "epigenetic aging" in unavailable tissues (e.g., brain). Despite the reproducible and accurate age predictions from DNA methylation data, these findings suggest they may have limited utility as currently designed in understanding the molecular biology of aging and may not be suitable as surrogate endpoints in studies of anti-aging interventions. Purpose-built clocks for specific tissues age ranges or phenotypes may perform better for their specific purpose. However, if purpose-built clocks are necessary for meaningful predictions, then the utility of clocks and their application in the field needs to be considered in that context.

DNA methylation-based biomarkers and the epigenetic clock theory of ageing

DNA methylation aging clocks: challenges and recommendations

DNA Methylation Clocks and Their Predictive Capacity for Aging Phenotypes and Healthspan

Epigenetic clock: A promising biomarker and practical tool in aging

DNA methylation markers to assess biological age

DNA Methylation Clocks in Aging: Categories, Causes, and Consequences

Quantification of Epigenetic Aging in Public Health

EPIGENETIC PREDICTORS OF LIFESPAN AND HEALTHSPAN

DNA methylation age as a biomarker for cancer

Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing

Many chronological aging clocks can be found throughout the epigenome: Implications for quantifying biological aging

An epigenetic biomarker of aging for lifespan and healthspan

Epigenetic aging: Biological age prediction and informing a mechanistic theory of aging

Utility of DNA Methylation as a Biomarker in Aging and Alzheimer's Disease

DNA methylation age of human tissues and cell types

A Path to Age Estimation through DNA Methylation

Epigenetic Clocks: In Aging-Related and Complex Diseases

DNA methylation and healthy human aging

Underlying features of epigenetic aging clocks in vivo and in vitro

Centenarian Clocks: Epigenetic Clocks for Validating Claims of Exceptional Longevity

ComputAgeBench: Epigenetic Aging Clocks Benchmark